Open access · CC-BY
via OpenAlex
The Insulin/IGF Signaling Regulators Cytohesin/GRP-1 and PIP5K/PPK-1 Modulate Susceptibility to Excitotoxicity in C. elegans
Nazila Tehrani, John Smith Del Rosario, Moises Dominguez, Robert Gordon Kalb, Itzhak Mano
PLoS ONE · 2014 · ▲ 9 citations
Abstract
During ischemic stroke, malfunction of excitatory amino acid transporters and reduced synaptic clearance causes accumulation of Glutamate (Glu) and excessive stimulation of postsynaptic neurons, which can lead to their degeneration by excitotoxicity. The balance between cell death-promoting (neurotoxic) and survival-promoting (neuroprotective) signaling cascades determines the fate of neurons exposed to the excitotoxic insult. The evolutionary conserved Insulin/IGF Signaling (IIS) cascade can participate in this balance, as it controls cell stress resistance in nematodes and mammals. Blocking the IIS cascade allows the transcription factor FoxO3/DAF-16 to accumulate in the nucleus and activate a transcriptional program that protects cells from a range of insults. We study the effect of IIS cascade on neurodegeneration in a C. elegans model of excitotoxicity, where a mutation in a central Glu transporter (glt-3) in a sensitizing background causes Glu-Receptor -dependent neuronal necrosis. We expand our studies on the role of the IIS cascade in determining susceptibility to excitotoxic necrosis by either blocking IIS at the level of PI3K/AGE-1 or stimulating it by removing the inhibitory effect of ZFP-1 on the expression of PDK-1. We further show that the components of the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex, known to regulate PIP2 production and the IIS cascade, modulate nematode excitotoxicity: mutations that are expected to reduce the complex's ability to produce PIP2 and inhibit the IIS cascade protect from excitotoxicity, while overstimulation of PIP2 production enhances neurodegeneration. Our observations therefore affirm the importance of the IIS cascade in determining the susceptibility to necrotic neurodegeneration in nematode excitotoxicity, and demonstrate the ability of Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex to modulate neuroprotection.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0113060
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Tehrani, N., Rosario, J.S.D., Dominguez, M., Kalb, R.G., & Mano, I. (2014). The Insulin/IGF Signaling Regulators Cytohesin/GRP-1 and PIP5K/PPK-1 Modulate Susceptibility to Excitotoxicity in C. elegans. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0113060
Vancouver
Tehrani N, Rosario JSD, Dominguez M, Kalb RG, Mano I. The Insulin/IGF Signaling Regulators Cytohesin/GRP-1 and PIP5K/PPK-1 Modulate Susceptibility to Excitotoxicity in C. elegans. PLoS ONE. 2014. doi:10.1371/journal.pone.0113060.
BibTeX
@article{nazila2014TheIns,
title = {The Insulin/IGF Signaling Regulators Cytohesin/GRP-1 and PIP5K/PPK-1 Modulate Susceptibility to Excitotoxicity in C. elegans},
author = {Nazila Tehrani and John Smith Del Rosario and Moises Dominguez and Robert Gordon Kalb and Itzhak Mano},
journal = {PLoS ONE},
year = {2014},
doi = {10.1371/journal.pone.0113060},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
CUNY Academic Works (City University of New York) 2015
Preprint · OA
The Insulin/IGF Signaling Regulator Cytohesin/GRP-1 Modulates Sensitivity to Excitotoxicity in C. elegans
BMB Reports 2016
Open access · CC-BY
The role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogaster
Journal of Alzheimer s Disease 2006
Citation only
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
PubMed 2007
Preprint
Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging.
The Journal of biological chemistry 2026
Open access · OA
Chronological lifespan extension and nucleotide salvage inhibition in yeast by isonicotinamide supplementation.
Genes & Development 2008
Preprint · OA